HEMATOPOIETIC RECONSTITUTION AFTER BUSULFAN CYCLOPHOSPHAMIDE CONDITIONING AND ALLOGENEIC BONE-MARROW TRANSPLANTATION

被引：0
|
作者：
SZCZYLIK, C
RATAJCZAK, MZ
URBANOWSKA, E
WIKTORJEDRZEJCZAK, W
机构：
[1] CSK WAM,DEPT IMMUNOL,PL-00909 WARSAW,POLAND
[2] POLISH ACAD SCI,CTR CLIN & EXPTL MED,PL-00784 WARSAW,POLAND
来源：
BLUT | 1988年 / 57卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：235 / 235
页数：1
相关论文
共 50 条
  • [31] BONE-MARROW TRANSPLANTATION IN THALASSEMIA AFTER BUSULFAN AND CYCLOPHOSPHAMIDE - REPORT ON 70 CASES
    LUCARELLI, G
    GALIMBERTI, M
    POLCHI, P
    DELFINI, C
    GIARDINI, C
    BARONCIANI, D
    POLITI, P
    MANENTI, F
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 216 - 216
  • [32] BONE-MARROW TRANSPLANTATION IN THALASSEMIA AFTER BUSULFAN AND CYCLOPHOSPHAMIDE - REPORT ON 88 CASES
    GALIMBERTI, M
    POLCHI, P
    LUCARELLI, G
    DELFINI, C
    POLITI, P
    GIARDINI, C
    BARONCIANI, D
    MANENTI, F
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 511 : 464 - 467
  • [33] Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning
    McCune, Jeannine S.
    Wang, Tao
    Bo-Subait, Khalid
    Aljurf, Mahmoud
    Beitinjaneh, Amer
    Bubalo, Joseph
    Cahn, Jean-Yves
    Cerny, Jan
    Chhabra, Saurabh
    Cumpston, Aaron
    Dupuis, L. Lee
    Lazarus, Hillard M.
    Marks, David I.
    Maziarz, Richard T.
    Norkin, Maxim
    Prestidge, Tim
    Mineishi, Shin
    Krem, Maxwell M.
    Pasquini, Marcelo
    Martin, Paul J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (07) : 1424 - 1431
  • [34] CONDITIONING REGIMENS FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION
    COPELAN, EA
    BLOOD REVIEWS, 1992, 6 (04) : 234 - 242
  • [35] REGIMEN-RELATED TOXICITY OF A BUSULFAN-CYCLOPHOSPHAMIDE CONDITIONING REGIMEN IN 70 PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    NEVILL, TJ
    BARNETT, MJ
    KLINGEMANN, HG
    REECE, DE
    SHEPHERD, JD
    PHILLIPS, GL
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (07) : 1224 - 1232
  • [36] EXTRAMEDULLARY TOXICITY OF A CONDITIONING REGIMEN CONTAINING BUSULFAN, CYCLOPHOSPHAMIDE AND ETOPOSIDE IN 84 PATIENTS UNDERGOING AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION
    CRILLEY, P
    TOPOLSKY, D
    STYLER, MJ
    BERNSTEIN, E
    RESNICK, K
    MULLANEY, R
    BULOVA, S
    BRODSKY, I
    MARKS, DI
    BONE MARROW TRANSPLANTATION, 1995, 15 (03) : 361 - 365
  • [37] UNRELATED ALLOGENEIC BONE-MARROW TRANSPLANTATION USING HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE (BU-CY) CONDITIONING REGIMEN
    SAHEBI, F
    BOLWELL, B
    CRILLEY, P
    FRANE, M
    TERRITO, M
    GAJEWSKI, J
    COPELAN, E
    BLOOD, 1993, 82 (10) : A81 - A81
  • [38] TREATMENT OF HIGH-RISK LEUKEMIA WITH BUSULFAN, CYCLOPHOSPHAMIDE, ETOPOSIDE AND ALLOGENEIC BONE-MARROW TRANSPLANTATION
    ALESSANDRINO, EP
    BERNASCONI, P
    BONFICHI, M
    CALDERA, D
    BONI, M
    BELLANTUONO, I
    BIAGGI, G
    BERNASCONI, C
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1132 - 1132
  • [39] RECOVERY OF CIRCULATING HEMATOPOIETIC PROGENITOR CELLS IN THE EARLY PHASE OF HEMATOPOIETIC RECONSTITUTION AFTER AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION
    KWONG, YL
    MILLAR, JL
    POWLES, RL
    BONE MARROW TRANSPLANTATION, 1989, 4 (05) : 575 - 578
  • [40] INCIDENCE OF MIXED CHIMERISM USING BUSULFAN CYCLOPHOSPHAMIDE CONTAINING REGIMENS IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
    FISHLEDER, AJ
    BOLWELL, B
    LICHTIN, AE
    BONE MARROW TRANSPLANTATION, 1992, 9 (04) : 293 - 297
12345